These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release. Lane DA, Cuddigan B, VanRoss M, Kakkar VV. Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460 [Abstract] [Full Text] [Related]
7. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A. Crum ED, Shainoff JR, Graham RC, Ratnoff OD. J Clin Invest; 1974 May; 53(5):1308-19. PubMed ID: 4856883 [Abstract] [Full Text] [Related]
8. Chromatographic, ultracentrifugal, and related studies of fibrinogen "Baltimore". Mosesson MW, Beck EA. J Clin Invest; 1969 Sep; 48(9):1656-62. PubMed ID: 5822576 [Abstract] [Full Text] [Related]
9. [Congenital dysfibrinogenemia. Report on a new family (fibrinogen "Wiesbaden")]. Winckelmann G. Thromb Diath Haemorrh Suppl; 1973 Sep; 55():345-56. PubMed ID: 4216115 [No Abstract] [Full Text] [Related]
10. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis. Al-Mondhiry H, Galanakis D. J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749 [Abstract] [Full Text] [Related]
11. Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule. Gralnick HR, Givelber H, Abrams E. N Engl J Med; 1978 Aug 03; 299(5):221-6. PubMed ID: 207986 [Abstract] [Full Text] [Related]
13. An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation. Hassan HJ, Orlando M, Tonini GP, Casalbore P, Sarti A, Boeri E, Giacchino R, Tentori L, Mori PG. Scand J Haematol; 1982 Oct 03; 29(4):287-94. PubMed ID: 7178834 [Abstract] [Full Text] [Related]
14. Fibrinogen Logroño. A new case of congenital dysfibrinogenemia. Rocha E, Lasierra J, Narvaiza MJ, Vilades E, Palacios E, Fernandez J. Ric Clin Lab; 1984 Oct 03; 14(4):663-72. PubMed ID: 6522973 [Abstract] [Full Text] [Related]
15. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin. Brown CH, Crowe MF. J Clin Invest; 1975 Jun 03; 55(6):1190-4. PubMed ID: 1133167 [Abstract] [Full Text] [Related]
16. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution. Borrell M, Vila L, Solá J, Coll I, Fontcuberta J. Haemostasis; 1990 Jun 03; 20(1):1-7. PubMed ID: 2323678 [Abstract] [Full Text] [Related]
17. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution. Loreth RM, Meyer M, Albert FW. Haemostasis; 2001 Jun 03; 31(1):12-7. PubMed ID: 11408744 [Abstract] [Full Text] [Related]
18. Fibrinogen Valencia. A new case of congenital dysfibrinogenemia. Aznar J, Fernandez-Pavón A, Regañón E, Vila V, Orellana F. Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):564-77. PubMed ID: 4217955 [No Abstract] [Full Text] [Related]
20. A kinetic method for characterization of heterogenous fibrinogen and its application to fibrinogen Grand Rapids, a congenital dysfibrinogenemia. Higgins DL, Lewis SD, Penner JA, Shafer JA. Thromb Haemost; 1982 Oct 29; 48(2):182-6. PubMed ID: 6217579 [Abstract] [Full Text] [Related] Page: [Next] [New Search]